To test the effect of Z-DG on food intake, 28 animals were injected with 750 mg/kg (ip) in three separate experiments (N = 9 in two, N = 10 in the third) beginning at 10-l 1 AM. Hourly food and water intakes were measured for the next 6 hr. The food intake on the experimental day was compared to the spontaneous food intake during the same time on the day prior to the experiment,
To compare the feeding elicited by Z-DG with that elicited by insulin, food intake was measured as described above in a group of 9 rats receiving 6 U regular insulin (Iletin, Lilly Co.) subcutaneously and a second group of 9 rats receiving 750 mg/kg Z-DG intraperitoneally. Insulin-induced feeding was also studied in 10 rats given 6 U regular insulin (Iletin) intraperitoneally. This experiment was performed to assure that the latency to the first bout of feeding after subcutaneous insulin was equal to or less than the latency after intraperitoneal insulin. In experiments designed to test the effect of Z-DG on plasma glucose, each rat in an additional group of 10 received 2-DG (750 rug/kg ip) at the beginning of the experiment, and then tail vein blood samples were obtained at 1, 3, and 6 hr after the injection.
Food and water were provided to only 4 of the rats during the experiments in which plasma glucose was measured.
Z-Deoxy-D-glucose (Calbiochem or Sigma Corp.) was kept frozen and the required amount was mixed (with Sterile water for monkeys or distilled water for rats) to provide a 5 % solution (monkeys) or a 10 % solution (rats) immediately before each experiment. All blood samples from experiments with Z-DG were centrifuged immediately; plasmas were separated, frozen, and analyzed for glucose concentration by the glucose oxidase method and, in a few instances, for Z-DG by the method of Cramer and Seville (5).
RESULTS
Monkey experiments. When Z-DG was injected intravenously prior to the Z-hr afternoon meal, food intake increased two-to fourfold in four of the five monkeys in the 1st hr following the injection (Table 1) . Food intake was not consistently increased during the 2nd hr of the meal. The most effective dose was 300 "g/kg.
When a dose of 500 mg/kg was injected, transient drowsiness (< 2-min duration), restlessness, and retching were frequently observed, but neither stupor nor convulsions were seen.
Fifteen minutes after Z-DG (300 mg/kg, iv) and the beginning of the meal, plasma glucose rose (Fig. 1) . Plasma glucose continued to increase throughout the hour of increased food intake. Peak values of plasma glucose occurred 60-90 min after the injection of 2-DG. In all cases, plasma glucose was returning toward control values by the end of the 2nd hr. Since Z-DG reacts slowly with glucose oxidase, the plasma glucose measurements in Fig. 1 might be a mixture of glucose and 2-DG. This is not likely, however, because when 2-DG was measured directly in three experi- ments, less than 1 mg/ 100 ml remained in the plasma 15 min after the injection of 2-DC. No dose of Z-DG produced a consistent increase in food intake in monkey 47, although 2-DG (300 mg/kg) produced hyperglycemic curves similar to that displayed in Fig. 1 . Monkey 47 was also exceptional in that doses of 33 mg/kg or 300 mg/kg completely inhibited food intake in three experiments.
Rat ex#riments. Feeding in rats was also markedly stimulated by Z-DG. In three separate experiments 28 animals were studied (N = 9 in two, N = 10 in the third) using 750 Tdkg (iP>, with which the best effects were obtained. The animals ate more and they ate sooner. Spontaneous intake of Purina pellets during the 6 hr of the test period on the day before 2-DG injection averaged 2.4 g (range: O.O-6.8 g). During the 6 hr after Z-DG, food intake averaged 4.9 g (range: 0.0-l 1.4 g). Of the 28 animals, 23 ate more (P < .Ol, Sign test).
Latency to the first bout of eating was considerably shorter in rats given Z-DG. As is shown in Table 2 and Fig.  2 , average latency measured in one group of nine rats decreased from 17 1 min (range: 23-360 min) on the day before injection to only 39 min (range: 9-198) after Z-DG. All of the nine rats ate sooner. Eight did so within 30 min after the injection (see Fig. 2 ). Only one of the animals had eaten spontaneously in less than 30 min (23 min) on the previous day. These latencies were also considerably shorter than those for the first bout of eating after a single subcutaneous dose of insulin (6 U Iletin) that produced comparable total food intakes for the 6-hr test (see Fig. 2 ). The average latency after insulin was 124 min (range: 24-360 min). Note also in Fig. 2 that there is considerable overlap between the sizes of the first meals eaten by the animals in both groups.
The insulin data in Fig. 2 2. Latency i n minutes and size i n grams of first meal i n two groups of ni ne rats following 2-DG (750 mg/kg, ip) or insulin (6 U I letin, sc) , elicited feeding after slightly longer latencies (N = 10, average latency = 165 min, range = 30-360 min). Despite the longer latencies to the first bout of eating, intraperitoneal insulin produced an increase of food intake comparable to that produced by subcutaneous insulin. Water was available during all tests. The animals drank in association with feeding and water/food ratios were elevated after Z-DG. Average ratios for the group of nine rats in which they were calculated were 0.89 (range: O.O-2.09) during spontaneous feeding and drinking and 2.22 (range: 1.73-5.40) after Z-DG. As in the monkeys, the rats ate during a severe and sustained hyperglycemia.
Changes in plasma glucose produced by 750 mg/kg Z-DG were studied in four rats permitted to eat (food intake shown at the bottom of Fig. 3 ) and in six deprived of food during the 6 hr after iniection.
The plasma results were not different between the animals that were given access to food and those that were not. They have been pooled and are shown at the top of Fig. 3 . Mean resting plasma glucose was 99.9 mg/ 100 ml, rose to 3 19.3 mg/ 100 ml at the first I-hr measurement, and remained elevated at 167.4 mg/lOO ml at 6 hr after injection.
The rats ate and drank despite the stupor and ataxia that appeared within minutes of the injection and persisted for several hours. Lower doses of 2-DG (200-500 mg/kg) produced less depression but smaller and less consistent stimulation of feeding. Higher doses, up to 1,000 "g/kg, yielded severe and prolonged depression followed by eating and, in one rat, retching.
All animals appeared normal the day after injection.
DISCUSSION
Rats and monkeys eat more shortly after an injection of Z-DG. Presumably, it is the metabolic state of decreased glucose utilization (glucoprivation) which drives the animals to eat more. Although glucoprivation was not demonstrated directly, the fact that 2-DG produced cerebral symp toxns characteristic of hypoglycemia (drowsiness, stupor, and ataxia) despite marked hyperglycemia strongly suggests that both cerebral and peripheral glucoprivation occurred in the animals. We believe that the production of cerebral glucoprivation by 2-DG is the critical event in this phenomenon (see below), but the data do not exclude the possibility that peripheral glucoprivation is of equal or greater importance.
It is also obvious that the experiments did not identify the neural or hormonal mechanisms which effect the increased feeding.
The threshold and dose-response relationship of the feeding effect of 2-DG varied in rats and monkeys as well as in individual animals of the same species. This variability is probably due to the fact that glucoprivation produced conflicting signals of varied intensity to the neural system which controls feeding. Glucoprivation not only produces a signal which drives animals to eat more, but glucoprivation also produces increased serum osmolarity (hyperglycemia) If cerebral glucoprivation is the effective condition which increases feeding, one would predict that animals would eat sooner after Z-DG than after large doses of insulin. This prediction was verified in the rat experiments ( Fig. 2 and Table 2 ). This fact combined with the demonstrated severe hyperglycemia that accompanied the increased feeding after Z-DG makes it abundantly clear that the level of blood sugar is not a direct control or predictor of food intake. The association of hypoglycemia (7) with hunger and hyperglycemia with satiety, which were at best terminologic conveniences, are now clearly obsolete. The fact that Z-DG produced increased feeding during marked hyperglycemia is reminiscent of the problem which the diabetic posed for the glucostatic hypothesis. It was this problem which originally focused attention on decreased glucose utilization as the critical variable rather than low blood sugar. Our results with Z-DG are much stronger evidence for the view that decreased glucose utilization is crucial for increased feeding because: I) The increased food intake seen after 2-DG occurs with an acute, reversible disturbance of glucose metabolism rather than a new, chronic metabolic state characteristic of diabetes.
2) The type of diabetes which the metabolic and hormonal responses to Z-DG resemble is maturity-onset diabetes (19). Of 182 maturity-onset diabetics specifically questioned about increased appetite, only 17 patients acknowledged its presence (1) . Furthermore, we know of no documented increase in food intake in maturity-onset diabetes.
3) We know of no evidence for increased food intake in any type of diabetes which could not be explained as a compensation for the urinary losses of metabolic substrates.
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